author's abstract.) The primary goal of the proposed research is to investigate the molecular mechanism(s) of toxicities consisting of myelosuppression (anemia) and peripheral neuropathy, as a result of the effects of 2',3'-dideoxynucleosides (ddN's) on the expression of specific genes. In completing the two major aims of their project, the Investigator expects that the basic cellular and molecular studies will provide a rational basis for future structural studies leading to the design of second and third generation, highly specific nucleoside analogs active against the human immunodeficiency virus (HIV).
Aim #1 : the elucidation of the mechanism(s) responsible for the anemia induced by AZT, by way of inhibition by AZT and AMT of genes that regulate hemoglobin synthesis. AMT is a newly-identified metabolite of AZT which as been demonstrated by these investigators to be highly toxic to human bone marrow progenitor cells. In the proposed research, the researchers will evaluate the mechanism(s) involved in AMT toxicity for human erythroid cells and its role in AZT-induced anemia observed in patients. They will assess the effects of AZT and AMT on the expression of genes that regulate globin synthesis and heme synthesis (including 5-aminolevulinate synthase, 5-aminolevulinate dehydrase, and phosphobilinogen deaminase) as compared to constitutively-expressed genes. The examination of novel ddN's currently being evaluated in Phase I trials-- such as 3'-fluorothymidine, shown to be very toxic in erythroid progenitor cells--will permit the investigators to evaluate structural factors potentially important for inhibition of globin and """"""""heme"""""""" gene expression. The influence of hemin on the expression of genes regulating the hemoglobin synthesis and affected by AZT and AMT will be examined in an attempt to elucidate the mechanism(s) responsible for hemin protective effects of AZT cytotoxicity in erythroid cells. Elucidation of inhibition of globin gene transcription by AZT will be ascertained in evaluating effects of AZT on the activity and amount of specific erythroid nuclear proteins, such as NF-E1 and NF-E2.
AIM 2 : the examination of toxicity with the elucidation of cellular and molecular mechanism(s) of dideoxycytodine (ddC), dideoxyinosine (ddI), and 2',3'-didhydro-2',3'-dideoxythymidine (d4T) as related to their effects on peripheral neurons. Using a PC-12 cell as a model, the researchers will study the effects of ddC, ddI, and d4T on neurite outgrowth and survival, including the effects of the ddN's on initiation of neurite outgrowth, priming, on neurite degeneration and regeneration, and on biological markers. They will: discriminate the effects of ddN's on electrophysiological function in the soma, neurite, and growth cones of PC-12 cells and multinucleated cells; elucidate the mechanism(s) of toxicity by evaluating effects of ddN's on mitochondrial DNA synthesis and neural-specific protein synthesis; and study the effects of ddN's on the expression of genes that regulate neurofilaments and microtubule-associated proteins.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI033239-03
Application #
2068241
Study Section
AIDS and Related Research Study Section 2 (ARRB)
Project Start
1992-04-01
Project End
1996-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Pharmacology
Type
Schools of Dentistry
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
el Kouni, Mahmoud H (2002) Trends in the design of nucleoside analogues as anti-HIV drugs. Curr Pharm Des 8:581-93
Coghlan, M E; Sommadossi, J P; Jhala, N C et al. (2001) Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: a report of 12 cases. Clin Infect Dis 33:1914-21
Kreimeyer, A; Schneider, B; Sarfati, R et al. (2001) NDP kinase reactivity towards 3TC nucleotides. Antiviral Res 50:147-56
Placidi, L; Cretton-Scott, E; Gosselin, G et al. (2000) Intracellular metabolism of beta-L-2',3'-dideoxyadenosine: relevance to its limited antiviral activity. Antimicrob Agents Chemother 44:853-8
Martin, L T; Cretton-Scott, E; Schinazi, R F et al. (1999) Pharmacokinetics of beta-L-2',3'-dideoxy-5-fluorocytidine in rhesus monkeys. Antimicrob Agents Chemother 43:920-4
Cui, L; Locatelli, L; Xie, M Y et al. (1997) Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells. J Pharmacol Exp Ther 280:1228-34
Martin, L T; Faraj, A; Schinazi, R F et al. (1997) Effect of stereoisomerism on the cellular pharmacology of beta-enantiomers of cytidine analogs in Hep-G2 cells. Biochem Pharmacol 53:75-87
Fedorov, I I; Kazmina, E M; Gurskaya, G V et al. (1997) Novel 3'-C/N-substituted 2',3'-beta-D-dideoxynucleosides as potential chemotherapeutic agents. 1. Thymidine derivatives: synthesis, structure, and broad spectrum antiviral properties. J Med Chem 40:486-94
Fowler, D A; Rosenthal, G J; Sommadossi, J P (1996) Effect of recombinant human hemoglobin on human bone marrow progenitor cells: protection and reversal of 3'-azido-3'-deoxythymidine-induced toxicity. Toxicol Lett 85:55-62
Bridges, E G; Trentesaux, C; Lahlil, R et al. (1996) 3'-Azido-3'-deoxythymidine inhibits erythroid-specific transcription factors in human erythroid K562 leukemia cells. Eur J Haematol 56:62-7

Showing the most recent 10 out of 24 publications